Publications by authors named "Ryoichi Akamatsu"
Patients often present with severe fatty liver (FL) due to insulin deficiency at the onset of diabetic ketoacidosis (DKA). On the other hand, glycogenic hepatopathy (GH) is a possible cause of liver dysfunction in patients with DKA. We herein report a case of type 1 diabetes mellitus with severe FL at the onset of DKA, who demonstrated subsequent marked liver dysfunction after achieving an improvement of FL.
View Article and Find Full Text PDFArticle Synopsis
- The study examined the impact of the Medtronic MiniMed 770G hybrid closed-loop system on blood sugar control and psychological well-being in individuals with type 1 diabetes.
- Over three months, participants showed significant improvements in time spent within the target glucose range, reduced high blood sugar levels, and lower glycated hemoglobin levels.
- However, there were no notable enhancements in psychological measures such as satisfaction or quality of life, which may have been affected by increased sensor calibration requirements.
Introduction: Dulaglutide is a long-acting glucagon-like peptide 1 receptor agonist that is administered once weekly for the treatment of type 2 diabetes. However, the immediate glucose-lowering effect of dulaglutide after the first administration and the factors affecting the efficacy of the drug remain unclear.
Methods: This study was a retrospective and observational study of 80 subjects with type 2 diabetes conducted in a hospitalized setting.